These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Dual Roles of Pin1 in Cancer Development and Progression. Han HJ; Choi BY; Surh YJ Curr Pharm Des; 2017 Nov; 23(29):4422-4425. PubMed ID: 28671058 [TBL] [Abstract][Full Text] [Related]
43. [Pin1: a multi-talented peptidyl prolyl cis-trans isomerase and a promising therapeutic target for human cancers]. Marsolier J; Weitzman JB Med Sci (Paris); 2014; 30(8-9):772-8. PubMed ID: 25174754 [TBL] [Abstract][Full Text] [Related]
44. The prolyl isomerase Pin1 interacts with and downregulates the activity of AMPK leading to induction of tumorigenicity of hepatocarcinoma cells. Khanal P; Kim G; Yun HJ; Cho HG; Choi HS Mol Carcinog; 2013 Oct; 52(10):813-23. PubMed ID: 22549912 [TBL] [Abstract][Full Text] [Related]
45. Negative Regulation of Peptidyl-Prolyl Isomerase Activity by Interdomain Contact in Human Pin1. Wang X; Mahoney BJ; Zhang M; Zintsmaster JS; Peng JW Structure; 2015 Dec; 23(12):2224-2233. PubMed ID: 26602185 [TBL] [Abstract][Full Text] [Related]
46. Peptidyl-prolyl isomerase inhibitors. Wang XJ; Etzkorn FA Biopolymers; 2006; 84(2):125-46. PubMed ID: 16302169 [TBL] [Abstract][Full Text] [Related]
47. The role of Pin1 in the development and treatment of cancer. Min SH; Zhou XZ; Lu KP Arch Pharm Res; 2016 Dec; 39(12):1609-1620. PubMed ID: 27572155 [TBL] [Abstract][Full Text] [Related]
48. Overexpression of the prolyl isomerase PIN1 promotes cell growth in osteosarcoma cells. Zhou L; Park BH; Park JH; Jang KY; Park HS; Wagle S; Lee KB; Kim JR Oncol Rep; 2013 Jan; 29(1):193-8. PubMed ID: 23129219 [TBL] [Abstract][Full Text] [Related]
49. Design, synthesis and biological evaluation of benzimidazole derivatives as novel human Pin1 inhibitors. Ma T; Huang M; Li A; Zhao F; Li D; Liu D; Zhao L Bioorg Med Chem Lett; 2019 Jul; 29(14):1859-1863. PubMed ID: 31103446 [TBL] [Abstract][Full Text] [Related]
50. Pin1 induction in the fibrotic liver and its roles in TGF-β1 expression and Smad2/3 phosphorylation. Yang JW; Hien TT; Lim SC; Jun DW; Choi HS; Yoon JH; Cho IJ; Kang KW J Hepatol; 2014 Jun; 60(6):1235-41. PubMed ID: 24530597 [TBL] [Abstract][Full Text] [Related]
51. Aryl indanyl ketones: efficient inhibitors of the human peptidyl prolyl cis/trans isomerase Pin1. Daum S; Erdmann F; Fischer G; Féaux de Lacroix B; Hessamian-Alinejad A; Houben S; Frank W; Braun M Angew Chem Int Ed Engl; 2006 Nov; 45(44):7454-8. PubMed ID: 17048295 [No Abstract] [Full Text] [Related]
52. Inhibition of the peptidyl-prolyl-isomerase Pin1 enhances the responses of acute myeloid leukemia cells to retinoic acid via stabilization of RARalpha and PML-RARalpha. Gianni' M; Boldetti A; Guarnaccia V; Rambaldi A; Parrella E; Raska I; Rochette-Egly C; Del Sal G; Rustighi A; Terao M; Garattini E Cancer Res; 2009 Feb; 69(3):1016-26. PubMed ID: 19155306 [TBL] [Abstract][Full Text] [Related]
53. Discovery of 4,6-bis(benzyloxy)-3-phenylbenzofuran as a novel Pin1 inhibitor to suppress hepatocellular carcinoma via upregulating microRNA biogenesis. Fan X; He H; Li J; Luo G; Zheng Y; Zhou JK; He J; Pu W; Zhao Y Bioorg Med Chem; 2019 Jun; 27(11):2235-2244. PubMed ID: 31027708 [TBL] [Abstract][Full Text] [Related]
54. Preparation of protein transduction domain-fused peptidyl prolyl cis/trans isomerase Pin1. Ohashi T; Teshima S; Hidaka M; Uchida T Biosci Biotechnol Biochem; 2010; 74(10):2067-70. PubMed ID: 20944414 [TBL] [Abstract][Full Text] [Related]
55. Mice lacking Pin1 develop normally, but are defective in entering cell cycle from G(0) arrest. Fujimori F; Takahashi K; Uchida C; Uchida T Biochem Biophys Res Commun; 1999 Nov; 265(3):658-63. PubMed ID: 10600477 [TBL] [Abstract][Full Text] [Related]
56. The rotamase Pin1 is up-regulated, hypophosphorylated and required for cell cycle progression in head and neck squamous cell carcinomas. Wiegand S; Dakic B; Rath AF; Makarova G; Sterz C; Meissner W; Bette M; Adamkiewicz J; Müller-Brüsselbach S; Müller R; Werner JA; Mandic R Oral Oncol; 2009 Oct; 45(10):e140-9. PubMed ID: 19502098 [TBL] [Abstract][Full Text] [Related]
57. Prolyl isomerase Pin1 acts downstream of miR200c to promote cancer stem-like cell traits in breast cancer. Luo ML; Gong C; Chen CH; Lee DY; Hu H; Huang P; Yao Y; Guo W; Reinhardt F; Wulf G; Lieberman J; Zhou XZ; Song E; Lu KP Cancer Res; 2014 Jul; 74(13):3603-16. PubMed ID: 24786790 [TBL] [Abstract][Full Text] [Related]
58. Synthesis and biological evaluation of pyrimidine derivatives as novel human Pin1 inhibitors. Cui G; Jin J; Chen H; Cao R; Chen X; Xu B Bioorg Med Chem; 2018 May; 26(8):2186-2197. PubMed ID: 29576270 [TBL] [Abstract][Full Text] [Related]
59. Overexpression of peptidyl-prolyl isomerase Pin1 attenuates hepatocytes apoptosis and secondary necrosis following carbon tetrachloride-induced acute liver injury in mice. Risal P; Park BH; Cho BH; Kim JC; Jeong YJ Pathol Int; 2012 Jan; 62(1):8-15. PubMed ID: 22192799 [TBL] [Abstract][Full Text] [Related]